Close

BMO Capital Reiterates Outperform Rating on Exelixis (EXEL)

May 20, 2024 9:56 AM EDT Send to a Friend
BMO Capital analyst George Farmertzer Darout reiterated an Outperform rating and $29.00 price target on Exelixis (NASDAQ: EXEL).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login